利用人工智能进行社区盲法眼底疾病筛查的成本效益和成本效用:中国上海的模型研究。

IF 7 2区 医学 Q1 BIOLOGY Computers in biology and medicine Pub Date : 2024-11-02 DOI:10.1016/j.compbiomed.2024.109329
Senlin Lin , Yingyan Ma , Liping Li , Yanwei Jiang , Yajun Peng , Tao Yu , Dan Qian , Yi Xu , Lina Lu , Yingyao Chen , Haidong Zou
{"title":"利用人工智能进行社区盲法眼底疾病筛查的成本效益和成本效用:中国上海的模型研究。","authors":"Senlin Lin ,&nbsp;Yingyan Ma ,&nbsp;Liping Li ,&nbsp;Yanwei Jiang ,&nbsp;Yajun Peng ,&nbsp;Tao Yu ,&nbsp;Dan Qian ,&nbsp;Yi Xu ,&nbsp;Lina Lu ,&nbsp;Yingyao Chen ,&nbsp;Haidong Zou","doi":"10.1016/j.compbiomed.2024.109329","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>With application of artificial intelligence (AI) in the disease screening, process reengineering occurred simultaneously. Whether process reengineering deserves special emphasis in AI implementation in the community-based blinding fundus diseases screening is not clear.</div></div><div><h3>Method</h3><div>Cost-effectiveness and cost-utility analyses were performed employing decision-analytic Markov models. A hypothetical cohort of community residents was followed in the model over a period of 30 1-year Markov cycles, starting from the age of 60. The simulated cohort was based on work data of the Shanghai Digital Eye Disease Screening program (SDEDS). Three scenarios were compared: centralized screening with manual grading-based telemedicine systems (Scenario 1), centralized screening with an AI-assisted screening system (Scenario 2), and process reengineered screening with an AI-assisted screening system (Scenario 3). The main outcomes were incremental cost-effectiveness ratio (ICER) and incremental cost-utility ratio (ICUR).</div></div><div><h3>Results</h3><div>Compared with Scenario 1, Scenario 2 results in incremental 187.03 years of blindness avoided and incremental 106.78 QALYs at an additional cost of $ 490010.62 per 10,000 people screened, with an ICER of $2619.98 per year of blindness avoided and an ICUR of $4589.13 per QALY. Compared with Scenario 1, Scenario 3 results in incremental 187.03 years of blindness avoided and incremental 106.78 QALYs at an additional cost of $242313.23 per 10,000 people screened, with an ICER of $1295.60 per year of blindness avoided and an ICUR of $2269.35 per QALY. Although Scenario 2 and 3 could be considered cost-effective, the screening cost of Scenario 3 was 27.6 % and the total cost was 1.1 % lower, with the same expected effectiveness and utility. The probabilistic sensitivity analyses show that Scenario 3 dominated 69.1 % and 70.3 % of simulations under one and three times the local GDP per capita thresholds.</div></div><div><h3>Conclusions</h3><div>AI can improve the cost-effectiveness and cost-utility of screenings, especially when process reengineering is performed. Therefore, process reengineering is strongly recommended when AI is implemented.</div></div>","PeriodicalId":10578,"journal":{"name":"Computers in biology and medicine","volume":"183 ","pages":"Article 109329"},"PeriodicalIF":7.0000,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost-effectiveness and cost-utility of community-based blinding fundus diseases screening with artificial intelligence: A modelling study from Shanghai, China\",\"authors\":\"Senlin Lin ,&nbsp;Yingyan Ma ,&nbsp;Liping Li ,&nbsp;Yanwei Jiang ,&nbsp;Yajun Peng ,&nbsp;Tao Yu ,&nbsp;Dan Qian ,&nbsp;Yi Xu ,&nbsp;Lina Lu ,&nbsp;Yingyao Chen ,&nbsp;Haidong Zou\",\"doi\":\"10.1016/j.compbiomed.2024.109329\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>With application of artificial intelligence (AI) in the disease screening, process reengineering occurred simultaneously. Whether process reengineering deserves special emphasis in AI implementation in the community-based blinding fundus diseases screening is not clear.</div></div><div><h3>Method</h3><div>Cost-effectiveness and cost-utility analyses were performed employing decision-analytic Markov models. A hypothetical cohort of community residents was followed in the model over a period of 30 1-year Markov cycles, starting from the age of 60. The simulated cohort was based on work data of the Shanghai Digital Eye Disease Screening program (SDEDS). Three scenarios were compared: centralized screening with manual grading-based telemedicine systems (Scenario 1), centralized screening with an AI-assisted screening system (Scenario 2), and process reengineered screening with an AI-assisted screening system (Scenario 3). The main outcomes were incremental cost-effectiveness ratio (ICER) and incremental cost-utility ratio (ICUR).</div></div><div><h3>Results</h3><div>Compared with Scenario 1, Scenario 2 results in incremental 187.03 years of blindness avoided and incremental 106.78 QALYs at an additional cost of $ 490010.62 per 10,000 people screened, with an ICER of $2619.98 per year of blindness avoided and an ICUR of $4589.13 per QALY. Compared with Scenario 1, Scenario 3 results in incremental 187.03 years of blindness avoided and incremental 106.78 QALYs at an additional cost of $242313.23 per 10,000 people screened, with an ICER of $1295.60 per year of blindness avoided and an ICUR of $2269.35 per QALY. Although Scenario 2 and 3 could be considered cost-effective, the screening cost of Scenario 3 was 27.6 % and the total cost was 1.1 % lower, with the same expected effectiveness and utility. The probabilistic sensitivity analyses show that Scenario 3 dominated 69.1 % and 70.3 % of simulations under one and three times the local GDP per capita thresholds.</div></div><div><h3>Conclusions</h3><div>AI can improve the cost-effectiveness and cost-utility of screenings, especially when process reengineering is performed. Therefore, process reengineering is strongly recommended when AI is implemented.</div></div>\",\"PeriodicalId\":10578,\"journal\":{\"name\":\"Computers in biology and medicine\",\"volume\":\"183 \",\"pages\":\"Article 109329\"},\"PeriodicalIF\":7.0000,\"publicationDate\":\"2024-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Computers in biology and medicine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0010482524014148\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Computers in biology and medicine","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0010482524014148","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:随着人工智能(AI)在疾病筛查中的应用,流程再造也同时发生。在社区盲法眼底疾病筛查中实施人工智能时,是否需要特别强调流程再造,目前尚不清楚:方法:采用决策分析马尔可夫模型进行成本效益和成本效用分析。模型中的社区居民假定队列从 60 岁开始,在 30 个 1 年马尔可夫周期内进行跟踪。模拟队列基于上海数字化眼病筛查项目(SDEDS)的工作数据。比较了三种方案:基于人工分级的远程医疗系统集中筛查(方案 1)、人工智能辅助筛查系统集中筛查(方案 2)和人工智能辅助筛查系统流程再造筛查(方案 3)。主要结果是增量成本效益比(ICER)和增量成本效用比(ICUR):与方案 1 相比,方案 2 可增加 187.03 年的防盲时间,增加 106.78 QALY,每筛查 10000 人的额外成本为 490010.62 美元,每防盲一年的 ICER 为 2619.98 美元,每 QALY 的 ICUR 为 4589.13 美元。与方案 1 相比,方案 3 可增加 187.03 年的失明避免率和 106.78 QALY,每 1 万人筛查的额外成本为 242313.23 美元,每一年失明避免率的 ICER 为 1295.60 美元,每 QALY 的 ICUR 为 2269.35 美元。尽管方案 2 和方案 3 可被视为具有成本效益,但在预期效果和效用相同的情况下,方案 3 的筛查成本降低了 27.6%,总成本降低了 1.1%。概率敏感性分析表明,在当地人均 GDP 临界值为 1 倍和 3 倍的情况下,方案 3 分别占 69.1% 和 70.3% 的模拟比例:人工智能可以提高筛查的成本效益和成本效用,尤其是在进行流程再造时。因此,强烈建议在实施人工智能时进行流程再造。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cost-effectiveness and cost-utility of community-based blinding fundus diseases screening with artificial intelligence: A modelling study from Shanghai, China

Background

With application of artificial intelligence (AI) in the disease screening, process reengineering occurred simultaneously. Whether process reengineering deserves special emphasis in AI implementation in the community-based blinding fundus diseases screening is not clear.

Method

Cost-effectiveness and cost-utility analyses were performed employing decision-analytic Markov models. A hypothetical cohort of community residents was followed in the model over a period of 30 1-year Markov cycles, starting from the age of 60. The simulated cohort was based on work data of the Shanghai Digital Eye Disease Screening program (SDEDS). Three scenarios were compared: centralized screening with manual grading-based telemedicine systems (Scenario 1), centralized screening with an AI-assisted screening system (Scenario 2), and process reengineered screening with an AI-assisted screening system (Scenario 3). The main outcomes were incremental cost-effectiveness ratio (ICER) and incremental cost-utility ratio (ICUR).

Results

Compared with Scenario 1, Scenario 2 results in incremental 187.03 years of blindness avoided and incremental 106.78 QALYs at an additional cost of $ 490010.62 per 10,000 people screened, with an ICER of $2619.98 per year of blindness avoided and an ICUR of $4589.13 per QALY. Compared with Scenario 1, Scenario 3 results in incremental 187.03 years of blindness avoided and incremental 106.78 QALYs at an additional cost of $242313.23 per 10,000 people screened, with an ICER of $1295.60 per year of blindness avoided and an ICUR of $2269.35 per QALY. Although Scenario 2 and 3 could be considered cost-effective, the screening cost of Scenario 3 was 27.6 % and the total cost was 1.1 % lower, with the same expected effectiveness and utility. The probabilistic sensitivity analyses show that Scenario 3 dominated 69.1 % and 70.3 % of simulations under one and three times the local GDP per capita thresholds.

Conclusions

AI can improve the cost-effectiveness and cost-utility of screenings, especially when process reengineering is performed. Therefore, process reengineering is strongly recommended when AI is implemented.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Computers in biology and medicine
Computers in biology and medicine 工程技术-工程:生物医学
CiteScore
11.70
自引率
10.40%
发文量
1086
审稿时长
74 days
期刊介绍: Computers in Biology and Medicine is an international forum for sharing groundbreaking advancements in the use of computers in bioscience and medicine. This journal serves as a medium for communicating essential research, instruction, ideas, and information regarding the rapidly evolving field of computer applications in these domains. By encouraging the exchange of knowledge, we aim to facilitate progress and innovation in the utilization of computers in biology and medicine.
期刊最新文献
An adaptive enhanced human memory algorithm for multi-level image segmentation for pathological lung cancer images. Integrating multimodal learning for improved vital health parameter estimation. Riemannian manifold-based geometric clustering of continuous glucose monitoring to improve personalized diabetes management. Transformative artificial intelligence in gastric cancer: Advancements in diagnostic techniques. Artificial intelligence and deep learning algorithms for epigenetic sequence analysis: A review for epigeneticists and AI experts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1